Matches in SemOpenAlex for { <https://semopenalex.org/work/W4281613325> ?p ?o ?g. }
Showing items 1 to 65 of
65
with 100 items per page.
- W4281613325 endingPage "8538" @default.
- W4281613325 startingPage "8538" @default.
- W4281613325 abstract "8538 Background: Response to preoperative systemic therapy may provide valuable information regarding tumor biology and prognosis. This is increasingly relevant nowadays considering the promising results from preoperative chemoimmunotherapy. This study aims to examine the prognostic role of preoperative chemosensitivity defined by TNM stage change in NSCLC. Methods: Patients with histologically confirmed clinical stage II-III NSCLC who have received preoperative chemotherapy followed by R0 curative surgery were identified in the NCDB between 2006 and 2017. Patients who have developed metastasis at the time of surgery, received any perioperative radiotherapy or single agent chemotherapy, or died within 90 days of surgery, were excluded. Preoperative chemosensitivity is categorized as ypT0N0, downstaged (pTNM < cTNM, excluding ypT0N0), and not downstaged (pTNM ≥ cTNM). Logistic regression was used to evaluate associations between chemosensitivity and demographic, clinical, and pathological factors. Log-rank was used for survival analysis and adjusted by cox regression for age, gender, race, year of diagnosis, academic center, insurance, comorbidity, histology, and clinical stage. Results: A total of 1266 patients were included, of whom 104 (8.2%) had ypT0N0, 575 (45.4%) were downstaged, while 587 (46.4%) were not. Female, diagnosis in recent years, treatment at academic centers, and squamous histology were significantly associated with better chemosensitivity, while clinical TNM stage, age, race, and comorbidity were not. Five-year overall survival rate is 81.2%, 57.7%, and 46.2%, respectively (log-rank p < 0.001). After Cox regression adjustment, compared with not downstaged, ypT0N0 (HR 0.28, 95% CI 0.17 – 0.45) and downstaged (HR 0.61, 95% CI 0.51 – 0.74) were independently associated with improved postoperative survival. Conclusions: Preoperative chemosensitivity defined by TNM stage change before and after chemotherapy may prognosticate NSCLC after curative surgery. It may be a useful clinical tool to identify patients with high risk of treatment failure after neoadjuvant chemoimmunotherapy in the future.[Table: see text]" @default.
- W4281613325 created "2022-06-12" @default.
- W4281613325 creator A5013007356 @default.
- W4281613325 creator A5015857422 @default.
- W4281613325 creator A5023960433 @default.
- W4281613325 creator A5045853797 @default.
- W4281613325 date "2022-06-01" @default.
- W4281613325 modified "2023-09-29" @default.
- W4281613325 title "Prognostic role of preoperative chemosensitivity in patients with non–small cell lung cancer (NSCLC) treated with preoperative chemotherapy: A study of National Cancer Database (NCDB)." @default.
- W4281613325 doi "https://doi.org/10.1200/jco.2022.40.16_suppl.8538" @default.
- W4281613325 hasPublicationYear "2022" @default.
- W4281613325 type Work @default.
- W4281613325 citedByCount "0" @default.
- W4281613325 crossrefType "journal-article" @default.
- W4281613325 hasAuthorship W4281613325A5013007356 @default.
- W4281613325 hasAuthorship W4281613325A5015857422 @default.
- W4281613325 hasAuthorship W4281613325A5023960433 @default.
- W4281613325 hasAuthorship W4281613325A5045853797 @default.
- W4281613325 hasConcept C121608353 @default.
- W4281613325 hasConcept C126322002 @default.
- W4281613325 hasConcept C141071460 @default.
- W4281613325 hasConcept C143998085 @default.
- W4281613325 hasConcept C146357865 @default.
- W4281613325 hasConcept C151730666 @default.
- W4281613325 hasConcept C2776256026 @default.
- W4281613325 hasConcept C2776694085 @default.
- W4281613325 hasConcept C2779159551 @default.
- W4281613325 hasConcept C31174226 @default.
- W4281613325 hasConcept C50382708 @default.
- W4281613325 hasConcept C71924100 @default.
- W4281613325 hasConcept C86803240 @default.
- W4281613325 hasConceptScore W4281613325C121608353 @default.
- W4281613325 hasConceptScore W4281613325C126322002 @default.
- W4281613325 hasConceptScore W4281613325C141071460 @default.
- W4281613325 hasConceptScore W4281613325C143998085 @default.
- W4281613325 hasConceptScore W4281613325C146357865 @default.
- W4281613325 hasConceptScore W4281613325C151730666 @default.
- W4281613325 hasConceptScore W4281613325C2776256026 @default.
- W4281613325 hasConceptScore W4281613325C2776694085 @default.
- W4281613325 hasConceptScore W4281613325C2779159551 @default.
- W4281613325 hasConceptScore W4281613325C31174226 @default.
- W4281613325 hasConceptScore W4281613325C50382708 @default.
- W4281613325 hasConceptScore W4281613325C71924100 @default.
- W4281613325 hasConceptScore W4281613325C86803240 @default.
- W4281613325 hasFunder F4320332161 @default.
- W4281613325 hasIssue "16_suppl" @default.
- W4281613325 hasLocation W42816133251 @default.
- W4281613325 hasOpenAccess W4281613325 @default.
- W4281613325 hasPrimaryLocation W42816133251 @default.
- W4281613325 hasRelatedWork W167319750 @default.
- W4281613325 hasRelatedWork W1987468340 @default.
- W4281613325 hasRelatedWork W2020432758 @default.
- W4281613325 hasRelatedWork W2277416945 @default.
- W4281613325 hasRelatedWork W2358450743 @default.
- W4281613325 hasRelatedWork W2372561159 @default.
- W4281613325 hasRelatedWork W2381460883 @default.
- W4281613325 hasRelatedWork W2413020017 @default.
- W4281613325 hasRelatedWork W2480785262 @default.
- W4281613325 hasRelatedWork W3031390371 @default.
- W4281613325 hasVolume "40" @default.
- W4281613325 isParatext "false" @default.
- W4281613325 isRetracted "false" @default.
- W4281613325 workType "article" @default.